Vertex's work on cystic fibrosis and other orphan drug areas demonstrates the policy rationale for the exemption: price controls can limit innovation in rare disease areas where the addressable market is small and harder to develop cures for.

normativepending

Speaker

Dan Clifton

Evidence Quote

“the price controls can limit innovation where we need the research in these more isolated areas”

Source

Big Beautiful Bill, Write-Off Revolution & Tariff Tempest — The Friday Market Wrap!— Steve Eisman
Created: 8/11/2026, 4:52:42 AM

Your notes

Loading notes...